DRACHMAN JONATHAN G 4
4 · Neoleukin Therapeutics, Inc. · Filed Aug 4, 2022
Insider Transaction Report
Form 4
DRACHMAN JONATHAN G
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-08-02+350,000→ 350,000 totalExercise: $0.99Exp: 2032-08-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total shares on August 2, 2023, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.